Peter A Olson insider trades
Open-market stock purchases and sales by Peter A Olson, Chief Scientific Officer at Iambic Therapeutics, Inc, from SEC Form 4 filings since Oct 14, 2026.
Companies traded
- IAM Iambic Therapeutics, Inc: other filings, last Oct 14, 2026